Hospital Infection Therapeutics Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Sep 2018| TMR913A| Transparency

Report Highlights

Hospital Infection Therapeutics Market - Overview

This report studies the current as well as future prospects of the global hospital infection therapeutics market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of hospital infection therapeutics and new players planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the global hospital infection therapeutics market regarding leading segments based on infection, therapeutics, and region.

The global hospital infection therapeutics market has been segmented based on therapeutics, infection, and region. In terms of therapeutics, the global market has been classified into anti-bacterial drugs, anti-fungal drugs, anti-viral drugs, and others. The others segment comprises drug classes such as anti-parasitic drugs. The anti-bacterial drugs segment has been divided into cell wall synthesis inhibitors, protein synthesis inhibitors, and others. The anti-fungal drugs segment has been categorized into Caspofungin, Amphotericin B, and others. Based on infection, the global hospital infection therapeutics market has been segmented into hospital acquired pneumonia, urinary tract infections, gastrointestinal disorders, bloodstream infections, surgical site infections, and other hospital infections.

The bottom-up approach for determining the market size was employed using various market indicators obtained from secondary sources, which include population in 2017, prevalence of all types of hospital acquired infections in major countries, variations in therapy cost across major regions, and approval of therapeutics in specific regions. The top-down approach was used to derive the market size for therapeutics segments, wherein revenues of all publicly listed market players were obtained through secondary sources and analyzed for hospital infection therapeutics specific revenues by narrowing down to revenue percentage for therapeutics segment through extensive secondary analysis of annual reports, investor presentations, press releases, primary interviews, and others. Data triangulation is based on secondary research (top-down and bottom-up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

The market overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have significant impact on the global hospital infection therapeutics market and could influence it in the near future. Market attractiveness analysis has been provided to explain the intensity of competition in the market across different regions. The competitive scenario among different market players has been evaluated through market share analysis in the competitive landscape section of the report. These factors are likely to help market players take strategic decisions to strengthen their positions and expand their shares in the global hospital infection therapeutics market. The report also comprises of regulatory scenario by region/global, pipeline analysis, reimbursement scenario by region/global, disease prevalence & incidence rate globally with key countries, health care industry overview, value chain analysis, and porter’s five forces analysis.

In terms of region, the global hospital infection therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and opportunities has been provided in the overview section. This section of the report also provides the market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global hospital infection therapeutics market.

Major players operating in the global hospital infection therapeutics market are Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, AstraZeneca, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Allergan plc, Sanofi S.A., Gilead Sciences, Inc., Basilea Pharmaceutica Ltd., and Bristol-Myers Squibb Company, among others.

The global hospital infection therapeutics market has been segmented as follows:

Global Hospital Infection Therapeutics Market, by Therapeutics
Anti-bacterial Drugs
Anti-fungal Drugs
Anti-viral Drugs
Others

Global Hospital Infection Therapeutics Market, by Infection
Hospital Acquired Pneumonia
Urinary Tract Infections
Gastrointestinal Disorders
Bloodstream Infections
Surgical Site Infections
Other Hospital Infections

Global Hospital Infection Therapeutics Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : WHO priority list and drug candidates in pre-clinical and clinical development
  • Table 2 : Pipeline Analysis of Hospital Infection Therapeutics (1/5)
  • Table 3 : Pipeline Analysis of Hospital Infection Therapeutics (2/5)
  • Table 4 : Pipeline Analysis of Hospital Infection Therapeutics (3/5)
  • Table 5 : Pipeline Analysis of Hospital Infection Therapeutics (4/5)
  • Table 6 : Pipeline Analysis of Hospital Infection Therapeutics (5/5)
  • Table 7 : Disease Prevalence & Incidence Rate Globally, by Key Countries
  • Table 8 : Healthcare Industry Overview
  • Table 9 : Incidence Rate (per 100,000 population) of S. aureus bacteremia, U.K., 2013 (1/2)
  • Table 10 : Incidence Rate (per 100,000 population) of S. aureus bacteremia, U.K., 2013 (2/2)
  • Table 11 : Global Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 12 : Global Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-bacterial Drugs, 2016–2026
  • Table 13 : Global Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-fungal Drugs, 2016–2026
  • Table 14 : Global Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Infection, 2016–2026
  • Table 15 : Global Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Region, 2016–2026
  • Table 16 : North America Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Country, 2016–2026
  • Table 17 : North America Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 18 : North America Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-bacterial Drugs, 2016–2026
  • Table 19 : North America Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-fungal Drugs, 2016–2026
  • Table 20 : North America Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Infection, 2016–2026
  • Table 21 : Europe Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 22 : Europe Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 23 : Europe Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-bacterial Drugs, 2016–2026
  • Table 24 : Europe Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-fungal Drugs, 2016–2026
  • Table 25 : Europe Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Infection, 2016–2026
  • Table 26 : Asia Pacific Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 27 : Asia Pacific Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 28 : Asia Pacific Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-bacterial Drugs, 2016–2026
  • Table 29 : Asia Pacific Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-fungal Drugs, 2016–2026
  • Table 30 : Asia Pacific Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Infection, 2016–2026
  • Table 31 : Latin America Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 32 : Latin America Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 33 : Latin America Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics
  • Table 34 : Latin America Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics
  • Table 35 : Latin America Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Infection, 2016–2026
  • Table 36 : Middle East & Africa Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 37 : Middle East & Africa Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 38 : Middle East & Africa Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Anti-bacterial Drugs, 2016–2026
  • Table 39 : Middle East & Africa Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Anti-fungal Drugs, 2016–2026
  • Table 40 : Middle East & Africa Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, by Infection, 2016–2026
  • Figure 1 : Global Hospital Infection Therapeutics Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 2 : Global Hospital Infection Therapeutics Market Value Share (%), by Therapeutics (2017)
  • Figure 3 : Global Hospital Infection Therapeutics Market Value Share (%), by Region (2017)
  • Figure 4 : Global Hospital Infection Therapeutics Market Value Share (%), by Infection (2017)
  • Figure 5 : Percentage Distribution of Population Aged 65 and Over, by Region: 2015
  • Figure 6 : Percentage Distribution of Population Aged 65 and Over, by Region: 2050
  • Figure 7 : Regulatory Approval Process - U.S.
  • Figure 8 : Regulatory Approval Process - Europe
  • Figure 9 : Regulatory Approval Process - Japan
  • Figure 10 : Global Hospital Infection Therapeutics Market Value Share (%), by Therapeutics, 2017 and 2026
  • Figure 11 : Global Hospital Infection Therapeutics Market Attractiveness, by Therapeutics, 2018–2026
  • Figure 12 : Global Hospital Infection Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anti-bacterial Drugs, 2016–2026
  • Figure 13 : Global Hospital Infection Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anti-fungal Drugs, 2016–2026
  • Figure 14 : Global Hospital Infection Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anti-viral Drugs, 2016–2026
  • Figure 15 : Global Hospital Infection Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
  • Figure 16 : Global Hospital Infection Therapeutics Market Value Share (%), by Infection, 2017 and 2026
  • Figure 17 : Global Hospital Infection Therapeutics Market Attractiveness, by Infection, 2018–2026
  • Figure 18 : Global Hospital Infection Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Acquired Pneumonia, 2016–2026
  • Figure 19 : Global Hospital Infection Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Urinary Tract Infections, 2016–2026
  • Figure 20 : Global Hospital Infection Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gastrointestinal Disorders, 2016–2026
  • Figure 21 : Global Hospital Infection Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Bloodstream Infections, 2016–2026
  • Figure 22 : Global Hospital Infection Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Surgical Site Infections, 2016–2026
  • Figure 23 : Global Hospital Infection Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Other Hospital Infections, 2016–2026
  • Figure 24 : Global Hospital Infection Therapeutics Market Value Share (%), by Region, 2017 and 2026
  • Figure 25 : Global Hospital Infection Therapeutics Market Attractiveness, by Region, 2018–2026
  • Figure 26 : North America Hospital Infection Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 27 : North America Hospital Infection Therapeutics Market Value Share (%), by Country, 2017 and 2026
  • Figure 28 : North America Hospital Infection Therapeutics Market Attractiveness, by Country, 2018–2026
  • Figure 29 : North America Hospital Infection Therapeutics Market Value Share (%), by Therapeutics, 2017 and 2026
  • Figure 30 : North America Hospital Infection Therapeutics Market Attractiveness, by Therapeutics, 2018–2026
  • Figure 31 : North America Hospital Infection Therapeutics Market Value Share (%), by Infection, 2017 and 2026
  • Figure 32 : North America Hospital Infection Therapeutics Market Attractiveness, by Infection, 2018–2026
  • Figure 33 : Europe Hospital Infection Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 34 : Europe Hospital Infection Therapeutics Market Value Share (%), by Country/Sub-region, 2017 and 2026
  • Figure 35 : Europe Hospital Infection Therapeutics Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 36 : Europe Hospital Infection Therapeutics Market Value Share (%), by Therapeutics, 2017 and 2026
  • Figure 37 : Europe Hospital Infection Therapeutics Market Attractiveness, by Therapeutics, 2018–2026
  • Figure 38 : Europe Hospital Infection Therapeutics Market Value Share (%), by Infection, 2017 and 2026
  • Figure 39 : Europe Hospital Infection Therapeutics Market Attractiveness, by Infection, 2018–2026
  • Figure 40 : Asia Pacific Hospital Infection Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 41 : Asia Pacific Hospital Infection Therapeutics Market Value Share (%), by Country/Sub-region, 2017 and 2026
  • Figure 42 : Asia Pacific Hospital Infection Therapeutics Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 43 : Asia Pacific Hospital Infection Therapeutics Market Value Share (%), by Therapeutics, 2017 and 2026
  • Figure 44 : Asia Pacific Hospital Infection Therapeutics Market Attractiveness, by Therapeutics, 2018–2026
  • Figure 45 : Asia Pacific Hospital Infection Therapeutics Market Value Share (%), by Infection, 2017 and 2026
  • Figure 46 : Asia Pacific Hospital Infection Therapeutics Market Attractiveness, by Infection, 2018–2026
  • Figure 47 : Latin America Hospital Infection Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 48 : Latin America Hospital Infection Therapeutics Market Value Share (%), by Country/Sub-region,
  • Figure 49 : Latin America Hospital Infection Therapeutics Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 50 : Latin America Hospital Infection Therapeutics Market Value Share (%), by Therapeutics, 2017 and 2026
  • Figure 51 : Latin America Hospital Infection Therapeutics Market Attractiveness, by Therapeutics, 2018–2026
  • Figure 52 : Latin America Hospital Infection Therapeutics Market Value Share (%), by Infection, 2017 and 2026
  • Figure 53 : Latin America Hospital Infection Therapeutics Market Attractiveness, by Infection, 2018–2026
  • Figure 54 : Middle East & Africa Hospital Infection Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 55 : Middle East & Africa Hospital Infection Therapeutics Market Value Share (%), by Country/Sub-region, 2017 and 2026
  • Figure 56 : Middle East & Africa Hospital Infection Therapeutics Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 57 : Middle East & Africa Hospital Infection Therapeutics Market Value Share (%), by Therapeutics, 2017 and 2026
  • Figure 58 : Middle East & Africa Hospital Infection Therapeutics Market Attractiveness, by Therapeutics, 2018–2026
  • Figure 59 : Middle East & Africa Hospital Infection Therapeutics Market Value Share (%), by Infection, 2017 and 2026
  • Figure 60 : Middle East & Africa Hospital Infection Therapeutics Market Attractiveness, by Infection, 2018–2026
  • Figure 61 : Global Hospital Infection Therapeutics Market Share, by Company, 2017
  • Figure 62 : Competition Matrix (1/2)
  • Figure 63 : Competition Matrix (2/2)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report